Coronary Disease
This article is part of CTSNet’s Guest Editor Series, Coronary Arterial Anomalies—Pediatric and Adult Congenital. CTSNet Senior Editor Dr. Sameh Said invited both pediatric and adult cardiac surgeons from around the world to contribute clinical...
In this article, the authors report interim results of Heart 2, a phase 1, open label, single ascending dose study of VERVE 102, a GalNAc lipid nanoparticle delivering mRNA for...
Thursday, March 4, 2027 – Saturday, March 6, 2027 @ 8:00 am – 12:00 pm – The Houston Aortic Symposium brings together world-renowned cardiothoracic and vascular surgeons to deliver cutting-edge...
This article examines the impact of surgery timing on postoperative outcomes in cardiac surgery. An analysis of data from 24,068 patients revealed that surgeries performed in the late morning (10:00...
Background and Rationale Coronary artery bypass graft (CABG) surgery remains a cornerstone treatment for advanced coronary heart disease. However, the long-term efficacy of CABG is frequently compromised by the failure...
In the ISCHEMIA Trial, 5179 patients with moderate or severe myocardial ischemia were randomized equally into two groups based on initial management strategy: initial invasive strategy (angiography and revascularization when...
This study of Medicare beneficiaries evaluated how often CABG was performed related to narrow intervals around a patient’s birthday. Those who were seen just prior to their 80th birthday (thus...
‘CABG was significantly better than PCI (p=0·0066……..”
...Following the withdrawal of the support of EACTS for the left main stem chapter of the EACTS/ESC Chapter of the revascularisation guidelines following the BBC Newsnight documentary of this, and...
In this randomized trial, percutaneous coronary intervention and CABG had equivalent outcomes for the composite of death, stroke, or myocardial infarction at five years for patients with left main disease...
This article reviews real-life outcomes of 42,714 patients undergoing coronary bypass grafting from 2005 to 2012. After adjusting for the differences in the populations, the patients who received multiple arterial...
Interesting clinicolaboratory experiment: Any translational value for the coronary surgeon and the cardiologist remains to be seen, especially regarding the risk stratification and prioritization for urgent (inpatient) revascularisation. Also, the...
Quite interesting to see that the incidence of revascularisation after multivessel PCA (the additional element on the second co-primary outcome) appears to have occured in more than 1% of the...




